Swedbank AB Purchases 272,913 Shares of Henry Schein, Inc. $HSIC

Key Points

• Swedbank AB increased its stake in Henry Schein, Inc. by 30.9%, acquiring an additional 272,913 shares during the second quarter, bringing its total ownership to 1,156,398 shares valued at approximately $84.5 million.
• Henry Schein reported earnings per share of $1.10, missing estimates by 9 cents, despite a year-over-year revenue increase of 3.3% to $3.24 billion.
• Analysts have mixed views on Henry Schein, with five analysts rating it as a Buy and seven as a Hold, while the average price target has been set at $76.67.

Swedbank AB boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 30.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,156,398 shares of the company's stock after acquiring an additional 272,913 shares during the period. Swedbank AB owned 0.95% of Henry Schein worth $84,475,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Investment Management Corp VA ADV bought a new stake in Henry Schein in the fourth quarter valued at approximately $32,000. Rakuten Securities Inc. bought a new stake in Henry Schein in the first quarter valued at approximately $34,000. Whittier Trust Co. boosted its holdings in Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after acquiring an additional 700 shares during the last quarter. Quarry LP bought a new stake in Henry Schein in the first quarter valued at approximately $71,000. Finally, UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HSIC has been the topic of several analyst reports. Barrington Research reduced their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Baird R W cut Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a report on Tuesday, August 26th. UBS Group cut their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a report on Wednesday, August 6th. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a report on Monday, July 14th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Hold" and a consensus target price of $76.67.

Henry Schein Stock Down 0.2%

NASDAQ:HSIC traded down $0.14 during trading hours on Monday, hitting $67.72. 156,779 shares of the company traded hands, compared to its average volume of 1,749,429. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm's 50-day simple moving average is $68.75 and its 200-day simple moving average is $69.33. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a market cap of $8.21 billion, a PE ratio of 21.86, a PEG ratio of 2.24 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the prior year, the business earned $1.23 earnings per share. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.